Format
Items per page
Sort by

Send to:

Choose Destination

Results: 15

1.

A comparison of the predictive accuracy of three screening models for pulmonary arterial hypertension in systemic sclerosis.

Hao Y, Thakkar V, Stevens W, Morrisroe K, Prior D, Rabusa C, Youssef P, Gabbay E, Roddy J, Walker J, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2015 Jan 18;17(1):7. [Epub ahead of print]

PMID:
25596924
[PubMed - as supplied by publisher]
2.

Potential role of the lectin pathway of complement in the pathogenesis and disease manifestations of systemic sclerosis: a case┬┐control and cohort study.

Osthoff M, Ngian GS, Dean MM, Nikpour M, Stevens W, Proudman S, Eisen DP, Sahhar J.

Arthritis Res Ther. 2014 Nov 18;16(6):480. [Epub ahead of print]

PMID:
25403109
[PubMed - as supplied by publisher]
Free PMC Article
3.

An Immunochip-based interrogation of scleroderma susceptibility variants identifies a novel association at DNASE1L3.

Zochling J, Newell F, Charlesworth JC, Leo P, Stankovich J, Cortes A, Zhou Y, Stevens W, Sahhar J, Roddy J, Nash P, Tymms K, Rischmueller M, Lester S, Proudman S, Brown MA.

Arthritis Res Ther. 2014 Oct 21;16(5):438. doi: 10.1186/s13075-014-0438-8.

PMID:
25332064
[PubMed - in process]
Free PMC Article
4.

Arterial stiffness is increased in systemic sclerosis: a cross-sectional comparison with matched controls.

Ngian GS, Sahhar J, Wicks IP, Van Doornum S.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-161-6. Epub 2014 Aug 15.

PMID:
25152081
[PubMed - in process]
5.

The association of antiphospholipid antibodies with cardiopulmonary manifestations of systemic sclerosis.

Morrisroe KB, Stevens W, Nandurkar H, Prior D, Thakkar V, Roddy J, Zochling J, Sahhar J, Tymms K, Sturgess A, Major G, Kermeen F, Hill C, Walker J, Nash P, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Clin Exp Rheumatol. 2014 Nov-Dec;32(6 Suppl 86):S-133-7. Epub 2014 Feb 24.

PMID:
24564981
[PubMed - in process]
6.

The inclusion of N-terminal pro-brain natriuretic peptide in a sensitive screening strategy for systemic sclerosis-related pulmonary arterial hypertension: a cohort study.

Thakkar V, Stevens W, Prior D, Youssef P, Liew D, Gabbay E, Roddy J, Walker JG, Zochling J, Sahhar J, Nash P, Lester S, Rischmueller M, Proudman SM, Nikpour M.

Arthritis Res Ther. 2013;15(6):R193.

PMID:
24246100
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease.

Moore OA, Goh N, Corte T, Rouse H, Hennessy O, Thakkar V, Byron J, Sahhar J, Roddy J, Gabbay E, Youssef P, Nash P, Zochling J, Proudman SM, Stevens W, Nikpour M.

Rheumatology (Oxford). 2013 Jan;52(1):155-60. doi: 10.1093/rheumatology/kes289. Epub 2012 Oct 13.

PMID:
23065360
[PubMed - indexed for MEDLINE]
Free Article
8.

Predictors of mortality in connective tissue disease-associated pulmonary arterial hypertension: a cohort study.

Ngian GS, Stevens W, Prior D, Gabbay E, Roddy J, Tran A, Minson R, Hill C, Chow K, Sahhar J, Proudman S, Nikpour M.

Arthritis Res Ther. 2012 Oct 5;14(5):R213. doi: 10.1186/ar4051.

PMID:
23039366
[PubMed - in process]
Free PMC Article
9.

N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study.

Thakkar V, Stevens WM, Prior D, Moore OA, Byron J, Liew D, Patterson K, Hissaria P, Roddy J, Zochling J, Sahhar J, Nash P, Tymms K, Celermajer D, Gabbay E, Youssef P, Proudman SM, Nikpour M.

Arthritis Res Ther. 2012 Jun 12;14(3):R143. doi: 10.1186/ar3876.

PMID:
22691291
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Prevalence of coronary heart disease and cardiovascular risk factors in a national cross-sectional cohort study of systemic sclerosis.

Ngian GS, Sahhar J, Proudman SM, Stevens W, Wicks IP, Van Doornum S.

Ann Rheum Dis. 2012 Dec;71(12):1980-3. doi: 10.1136/annrheumdis-2011-201176. Epub 2012 Apr 24.

PMID:
22532628
[PubMed - indexed for MEDLINE]
11.

Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort.

Nikpour M, Hissaria P, Byron J, Sahhar J, Micallef M, Paspaliaris W, Roddy J, Nash P, Sturgess A, Proudman S, Stevens W.

Arthritis Res Ther. 2011;13(6):R211. doi: 10.1186/ar3544. Epub 2011 Dec 22.

PMID:
22189167
[PubMed - indexed for MEDLINE]
Free PMC Article
12.

Cardiovascular disease in systemic sclerosis--an emerging association?

Ngian GS, Sahhar J, Wicks IP, Van Doornum S.

Arthritis Res Ther. 2011 Aug 26;13(4):237. doi: 10.1186/ar3445. Review.

PMID:
21888685
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Red flags in scleroderma.

Li Q, Sahhar J, Littlejohn G.

Aust Fam Physician. 2008 Oct;37(10):831-4. Review.

PMID:
19002303
[PubMed - indexed for MEDLINE]
Free Article
14.

Pulmonary arterial hypertension in systemic sclerosis: the need for early detection and treatment.

Proudman SM, Stevens WM, Sahhar J, Celermajer D.

Intern Med J. 2007 Jul;37(7):485-94. Review.

PMID:
17547726
[PubMed - indexed for MEDLINE]
15.

Fibrosing alveolitis in systemic sclerosis: the need for early screening and treatment.

Sahhar J, Littlejohn G, Conron M.

Intern Med J. 2004 Nov;34(11):626-38. Review.

PMID:
15546457
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk